Network

Coordinator Professor and Deputy Director of the Division of Clinical Pharmacology Ludwig-Maximilians-Universität Division of Clinical Pharmacology

Director Department of Medicine III, University Hospital, LMU Munich Spokesperson German Cancer Consortium Munich-LMU Ludwig-Maximilians-Universität Medizinische Klinik und Poliklinik III Klinikum der Universität München

Professor for Cancer- and Immunometabolism, Attending Physician, Lead of Myeoma Program Ludwig-Maximilians-Universität Gene Center Munich

Professor Danmarks Tekniske Universitet Department of Health Technology Kemitorvet

Professor Translational Tumor Immunology and Head of the Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers Dept. Medical Oncology Amsterdam UMC

Associate Professor of Immunology at INSERM Institut National de la Santé et de la Recherche Médicale INSERM U1100

Head of Molecular Biotechnology and Gene Therapy Paul-Ehrlich-Institut

Senior Research Associate and Regulatory Assessor Paul-Ehrlich-Institut Division of Medical Biotechnology

Director of Center for Cancer Immunotherapy Region Hovedstaden, University Hospital Herlev Center for Cancer Immunotherapy

Head Cancer Immunology Universität Basel Department of Biomedicine (DBM)

Research Group Leader of Cancer Immunotherapy Universität Basel Department of Biomedicine (DBM)

Department Head Cancer Immunotherapy Discovery 3 & Site Head Roche Innovation Center Zurich, Roche Pharma Research & Early Development Roche Glycart AG, Roche Innovation Center Zurich

Chief Strategy Advisor Instil Bio Inc

Professor of Immunology at UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay

Group Leader - R&D Reagents CAR technology research and translation - Miltenyi Biotec B.V. & Co. KG

Team Coordinator clinical T cell processing development R&D Immunotherapy - Miltenyi Biotec B.V. & Co. KG

Head of Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO

CSO Intelligent OMICS Ltd

ESR1, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich

ESR2, Reker's Lab, Danmarks Tekniske Universitet Department of Health Technology Kemitorvet

ESR 3, de Gruijl's Lab, Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers, Dept. Medical Oncology Amsterdam UMC

ESR4, Apetoh's Lab, Institut National de la Santé et de la Recherche Médicale INSERM U1100

ESR 5, Buchholz's Group, Paul-Ehrlich-Institut Division of Medical Biotechnology

ESR 6, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev

ESR 7, Zippelius and Läubli's Lab, Cancer Immunology, Cancer Immunotherapy, Department of Biomedicine (DBM), Universität Basel

ESR 8, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich

ESR 9, Klein's Lab, Department Cancer Immunotherapy Discovery 3, Roche Pharma Research & Early Development, Roche Glycart AG, Roche Innovation Center Zurich

ESR 10, Hawkin's Lab, InstilBio Inc

ESR 11, Zitvogel's Lab, UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay

ESR 12, Theurich's Lab, Gene Center Munich, Ludwig-Maximilians-Universität Munich

ESR 13, Mittelstätt and Schallenberg's Group, R&D Reagents CAR technology research and translation, Team clinical T cell processing development Miltenyi Biotec B.V. & Co. KG

ESR 14, thor Straten's Lab, Center for Cancer Immunotherapy, Region Hovedstaden, University Hospital Herlev